chr16-30707552-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006662.3(SRCAP):c.493-20C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.192 in 1,610,278 control chromosomes in the GnomAD database, including 33,338 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 2205 hom., cov: 32)
Exomes 𝑓: 0.20 ( 31133 hom. )
Consequence
SRCAP
NM_006662.3 intron
NM_006662.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.220
Publications
6 publications found
Genes affected
SRCAP (HGNC:16974): (Snf2 related CREBBP activator protein) This gene encodes the core catalytic component of the multiprotein chromatin-remodeling SRCAP complex. The encoded protein is an ATPase that is necessary for the incorporation of the histone variant H2A.Z into nucleosomes. It can function as a transcriptional activator in Notch-mediated, CREB-mediated and steroid receptor-mediated transcription. Mutations in this gene cause Floating-Harbor syndrome, a rare disorder characterized by short stature, language deficits and dysmorphic facial features. [provided by RefSeq, Feb 2012]
SRCAP Gene-Disease associations (from GenCC):
- developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalitiesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- Floating-Harbor syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 16-30707552-C-T is Benign according to our data. Variant chr16-30707552-C-T is described in ClinVar as [Benign]. Clinvar id is 260018.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.214 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRCAP | ENST00000262518.9 | c.493-20C>T | intron_variant | Intron 5 of 33 | 2 | NM_006662.3 | ENSP00000262518.4 | |||
ENSG00000282034 | ENST00000380361.7 | n.436-20C>T | intron_variant | Intron 2 of 30 | 2 | ENSP00000369719.3 | ||||
SRCAP | ENST00000411466.7 | c.493-20C>T | intron_variant | Intron 5 of 33 | 3 | ENSP00000405186.3 | ||||
SRCAP | ENST00000706321.1 | c.493-20C>T | intron_variant | Intron 5 of 33 | ENSP00000516346.1 |
Frequencies
GnomAD3 genomes AF: 0.149 AC: 22708AN: 152000Hom.: 2205 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
22708
AN:
152000
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.149 AC: 36377AN: 243938 AF XY: 0.151 show subpopulations
GnomAD2 exomes
AF:
AC:
36377
AN:
243938
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.197 AC: 286825AN: 1458160Hom.: 31133 Cov.: 33 AF XY: 0.194 AC XY: 140975AN XY: 725018 show subpopulations
GnomAD4 exome
AF:
AC:
286825
AN:
1458160
Hom.:
Cov.:
33
AF XY:
AC XY:
140975
AN XY:
725018
show subpopulations
African (AFR)
AF:
AC:
1236
AN:
33444
American (AMR)
AF:
AC:
4957
AN:
43936
Ashkenazi Jewish (ASJ)
AF:
AC:
3428
AN:
26046
East Asian (EAS)
AF:
AC:
31
AN:
39668
South Asian (SAS)
AF:
AC:
7779
AN:
85914
European-Finnish (FIN)
AF:
AC:
10818
AN:
53228
Middle Eastern (MID)
AF:
AC:
716
AN:
5586
European-Non Finnish (NFE)
AF:
AC:
246979
AN:
1110120
Other (OTH)
AF:
AC:
10881
AN:
60218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
12261
24522
36783
49044
61305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8228
16456
24684
32912
41140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.149 AC: 22707AN: 152118Hom.: 2205 Cov.: 32 AF XY: 0.147 AC XY: 10965AN XY: 74384 show subpopulations
GnomAD4 genome
AF:
AC:
22707
AN:
152118
Hom.:
Cov.:
32
AF XY:
AC XY:
10965
AN XY:
74384
show subpopulations
African (AFR)
AF:
AC:
1880
AN:
41492
American (AMR)
AF:
AC:
2298
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
507
AN:
3470
East Asian (EAS)
AF:
AC:
6
AN:
5186
South Asian (SAS)
AF:
AC:
385
AN:
4820
European-Finnish (FIN)
AF:
AC:
2345
AN:
10578
Middle Eastern (MID)
AF:
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14776
AN:
67978
Other (OTH)
AF:
AC:
306
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
946
1891
2837
3782
4728
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
160
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:3
May 07, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Floating-Harbor syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.